| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Boston Scientific Corp (BSX) has 9 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. BSX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 168.0K | $7.62M | - | |
| CFO | 35.8K | $1.62M | - | |
| VP | 35.4K | $1.61M | - | |
| VP | 30.6K | $1.39M | - | |
| Dir | 24.1K | $1.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2022 | Pierce David A47 | EVP Pres Medsurg | Sale+OE | 1,956 | $43.81 | $85,692.36 | -100% | -6.5% | +5.2% | |
| Feb 7, 2022 | Sorenson John Bradley55 | SVP, Global Supply Chain | Sell | 13,167 | $43.20 | $568,815.72 | -27.6% | -10.8% | +12.1% | |
| Jan 4, 2022 | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 6,840 | $43.54 | $297,806.08 | -4.9% | +1.2% | +6.6% | |
| Jan 4, 2022 | Pierce David A47 | EVP Pres Medsurg | Sell | 6,161 | $43.54 | $268,229.61 | -100% | +1.2% | +6.6% | |
| Jan 3, 2022 | Olson Scott46 | SVP &Pres, Crm, Diagnostics | Sell | 700 | $42.59 | $29,813.00 | -5.5% | +2.4% | +6.7% | |
| Dec 28, 2021 | Meredith Ian T | EVP Global Chief Med Officer | Sell | 7,018 | $43.21 | $303,247.78 | -21.1% | +2.4% | +5.9% | |
| Dec 20, 2021 | Pierce David A47 | EVP Pres Medsurg | Sale+OE | 49,988 | $39.90 | $1,994,621.18 | -100% | +12.2% | +16.1% | |
| Dec 15, 2021 | Carruthers Wendy | SVP, Human Resources | Sell | 3,321 | $40.83 | $135,596.43 | -2.1% | +6.0% | +15.1% | |
| Nov 15, 2021 | Carruthers Wendy | SVP, Human Resources | Sell | 3,321 | $42.18 | $140,079.78 | -2.1% | +3.4% | +2.6% | |
| Nov 15, 2021 | Wichmann David S | Director | Buy | 25,000 | $41.98 | $1,049,450.00 | New | +3.4% | +2.6% |